These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 18450897

  • 1. Underimmunization of American Indian and Alaska Native children.
    Groom AV, Washington ML, Smith PJ, Bryan RT.
    Pediatrics; 2008 May; 121(5):938-44. PubMed ID: 18450897
    [Abstract] [Full Text] [Related]

  • 2. Evaluating vaccination coverage and timeliness in American Indian/Alaska Native and non-Hispanic White children using state immunization information system data, 2015-2017.
    Michels SY, Freeman RE, Williams E, Albers AN, Wehner BK, Rechlin A, Newcomer SR.
    Prev Med Rep; 2022 Jun; 27():101817. PubMed ID: 35656223
    [Abstract] [Full Text] [Related]

  • 3. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease.
    Singleton R, Hammitt L, Hennessy T, Bulkow L, DeByle C, Parkinson A, Cottle TE, Peters H, Butler JC.
    Pediatrics; 2006 Aug; 118(2):e421-9. PubMed ID: 16882783
    [Abstract] [Full Text] [Related]

  • 4. Vaccination coverage of 2-year-old children--United States, 1992-1993.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1994 Apr 22; 43(15):282-3. PubMed ID: 8164635
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. From the Centers for Disease Control and Prevention. Childhood vaccines--United States, 1995-1999.
    JAMA; 2001 Dec 26; 286(24):3073-4. PubMed ID: 11787489
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Vaccination Coverage Among Children Aged 19-35 Months - United States, 2015.
    Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Dietz V.
    MMWR Morb Mortal Wkly Rep; 2016 Oct 07; 65(39):1065-1071. PubMed ID: 27711036
    [Abstract] [Full Text] [Related]

  • 11. Vaccination coverage among American Indian and Alaska native children, 2006-2010.
    Groom AV, Santibanez TA, Bryan RT.
    Pediatrics; 2012 Dec 07; 130(6):e1592-9. PubMed ID: 23166344
    [Abstract] [Full Text] [Related]

  • 12. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA, Ferrera G, Tran C, Thomas S, Eymin C, Baudin M.
    Vaccine; 2015 May 11; 33(20):2379-86. PubMed ID: 25765966
    [Abstract] [Full Text] [Related]

  • 13. Epidemiology of pertussis and Haemophilus influenzae type b disease in Canada with exclusive use of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b pediatric combination vaccine and an adolescent-adult tetanus-diphtheria-acellular pertussis vaccine: implications for disease prevention in the United States.
    Greenberg DP, Doemland M, Bettinger JA, Scheifele DW, Halperin SA, IMPACT Investigators, Waters V, Kandola K.
    Pediatr Infect Dis J; 2009 Jun 11; 28(6):521-8. PubMed ID: 19436236
    [Abstract] [Full Text] [Related]

  • 14. Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.
    Stein-Zamir C, Israeli A.
    Hum Vaccin Immunother; 2017 Sep 02; 13(9):2102-2110. PubMed ID: 28696824
    [Abstract] [Full Text] [Related]

  • 15. Does concomitant injection of a combined diphtheria-tetanus-acellular pertussis - hepatitis B virus - inactivated polio virus vaccine influence the reactogenicity and immunogenicity of commercial Haemophilus influenzae type b conjugate vaccines?
    Usonis V, Bakasenas V.
    Eur J Pediatr; 1999 May 02; 158(5):398-402. PubMed ID: 10333123
    [Abstract] [Full Text] [Related]

  • 16. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B, Wald E, Guerra N, Byers C.
    Pediatrics; 1990 Apr 02; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
    Lagos R, Kotloff K, Hoffenbach A, San Martin O, Abrego P, Ureta AM, Pines E, Blondeau C, Bailleux F, Levine MM.
    Pediatr Infect Dis J; 1998 Apr 02; 17(4):294-304. PubMed ID: 9576383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.